Divyani Pandey has been elevated to the role of Group Brand Lead at Cipla, marking a significant milestone in her career journey in the pharmaceutical industry. Based in Mumbai, she will now spearhead Cipla’s brand leadership initiatives, driving strategies that merge science, innovation, and market insights to strengthen the company’s presence in the healthcare sector.
With over five years of rich experience across leading pharma companies, Divyani has consistently demonstrated her expertise in brand strategy, scientific engagement, and market-building initiatives. In her previous role as Product Manager at Sun Pharma, she led the brand strategy for Istamet D, a key diabetes therapy brand, where she crafted impactful campaigns, drove digital engagement with healthcare professionals, and empowered field teams with insight-driven tools.
Prior to this, Divyani served as Senior Product Executive at Mankind Pharma, where she handled Jusoza M and played a pivotal role in the launch of Nobeglar, a long-acting basal insulin. Her efforts included building scientific campaigns, conducting MR training sessions, and creating robust in-clinic execution strategies that enabled stronger engagement with doctors and pharmacists.
Her career foundation was laid at Koye Pharmaceuticals and Medicom Healthcare, where she gained end-to-end exposure in cardio-diabetes portfolios, honed her skills in data analytics, scientific content development, and promotional strategy. This holistic experience has equipped her with the ability to blend data, science, and storytelling to build impactful healthcare brands.
At Cipla, Divyani’s leadership is expected to further enhance the organization’s vision of delivering high-quality, innovative therapies while strengthening brand trust among patients and healthcare professionals. Her elevation reflects not just her professional growth but also Cipla’s focus on empowering strong leaders to drive its next phase of brand excellence.